Section 192.020

There are multiple enactments of 192.020

Title XII PUBLIC HEALTH AND WELFARE

Chapter 192

Effective - 28 Aug 2026, 4 histories, see footnote   

  192.020.  Duty to safeguard the health of the people of Missouri — certain diseases to be included on communicable or infectious disease list — reporting to department, when. — 1.  It shall be the general duty and responsibility of the department of health and senior services to safeguard the health of the people in the state and all its subdivisions.  It shall make a study of the causes and prevention of diseases.  It shall designate those diseases which are infectious, contagious, communicable or dangerous in their nature and shall make and enforce adequate orders, findings, rules and regulations to prevent the spread of such diseases and to determine the prevalence of such diseases within the state.  It shall have power and authority, with approval of the director of the department, to make such orders, findings, rules and regulations as will prevent the entrance of infectious, contagious and communicable diseases into the state.

  2.  The department of health and senior services shall include in its list of communicable or infectious diseases which must be reported to the department methicillin-resistant staphylococcus aureus (MRSA), carbapenem-resistant enterobacteriaceae (CRE) as specified by the department, vancomycin-resistant enterococcus (VRE), and alpha-gal syndrome.

  3.  (1)  A laboratory blood test result for alpha-gal immunoglobulin E that yields a level consistent with sensitization to alpha-gal by laboratory standards, as established by the current national case definition, shall be reported to the department within seven days.  The laboratory that generates the test results shall be responsible for submitting the report.  The test results shall be submitted using an electronic laboratory reporting system to be developed by the department.

  (2)  Subject to appropriation, the department may follow up on reported cases of alpha-gal immunoglobulin E blood test results by applying an appropriate random sampling method to ascertain case status, using the current national case definition of alpha-gal syndrome.  Reporting under this subdivision shall commence no later than six months after August 28, 2026.

  (3)  The department shall submit an annual report to the Centers for Disease Control and Prevention summarizing its findings related to the reporting and incidence of alpha-gal syndrome.

  (4)  The laboratory and the department shall not disclose the identifiable test result or other protected health information relating to any individual for which a blood test is obtained to anyone other than the individual for which the blood test result is obtained and the health care provider ordering the laboratory blood test.

­­--------

(RSMo 1939 §§ 9735, 9736, A.L. 1945 p. 945 § 14, A.L. 1951 p. 784, A.L. 2004 S.B. 1279, A.L. 2016 S.B. 579, A.L. 2026 H.B. 2372)

Prior revisions: 1929 §§ 9015, 9016; 1919 §§ 5772, 5773; 1909 § 6653